Home > Mumbai > Mumbai News > Article > 100 pc samples from Mumbai found infected with Omicron sub variants in latest genome sequencing

100 pc samples from Mumbai found infected with Omicron sub-variants in latest genome sequencing

Updated on: 11 August,2022 09:25 PM IST  |  Mumbai
PTI |

Of the 230 patients whose samples were tested, 74 persons had not taken even a single dose of vaccines against Covid-19, and 19 of them were admitted to hospitals, the civic body said in a release

100 pc samples from Mumbai found infected with Omicron sub-variants in latest genome sequencing

Representative image. Pic/Istock


All 230 swab samples collected from Mumbai in June-July were found to have been infected by Omicron sub-variants of coronavirus, the Brihanmumbai Municipal Corporation (BMC) said on Thursday.


Of the 230 patients whose samples were tested, 74 persons had not taken even a single dose of vaccines against Covid-19, and 19 of them were admitted to hospitals, the civic body said in a release.

Three of these patients ended up in ICU, it said.


Also Read: Corbevax likely to be available at vaccination centres from tomorrow

The Public Health Department of the civic body appealed to the people to strictly follow the measures prescribed for controlling the spread of the virus.

Genome sequencing of samples from the city is being conducted periodically since last year to find out which subvariants of the virus are prevalent.

The results of the 14th round of genome sequencing showed that out of 230 samples, 64 or 28 per cent had BA 2.74 variant infection, 45 each were infected by BA 2.75 and 2.76 variants, another 28 samples showed BA 2.38 infection and 19 samples showed the presence of BA 5 variant, among others.

Most of these patients had mild Covid-19 symptoms, the BMC said.

A 43-year-old male Covid-19 patient having diabetes and heart disease died due to coronavirus infection, the release said.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK